Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. (Q44451380)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2003

Language	Label	Description	Also known as
English	Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.	scientific article published in June 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Eugene R Schiff

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Selim Karayalcin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Robert P Perrillo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

R A de Man

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Zachary Goodman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Lynn D Condreay

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Lynn M Crowther

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Mary A Woessner

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Penny J McPhillips

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Nathaniel A Brown

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

International Lamivudine Investigator Group

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

818-826

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in chronic hepatitis B. An analysis of 379 patients

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and prognostic factors for chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predictive of response to interferon therapy in children with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon in the management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Side effects of alpha interferon

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(03)50076-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(03)00076-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763376 AND SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44451380&oldid=1590396229"